Table 3.
Bacterial strain | Besifloxacin: MIC90 | Comparator(s): MIC90 |
---|---|---|
Susceptible S. aureusa | 0.03–0.5 μg/mL | N/A |
Susceptible S. epidermidisa | 0.03–0.5 μg/mL | N/A |
Susceptible S. pneumoniaea | 0.03–0.5 μg/mL | N/A |
Susceptible H. influenzaea | 0.03–0.5 μg/mL | N/A |
MRSA | 0.06 μg/mL | N/A |
Vancomycin-intermediate S. aureus | 2 μg/mL | N/A |
Methicillin/ciprofloxacin-resistant S. aureus | 8 μg/mL | N/A |
Penicillin-resistant S. pneumoniae | 0.12 μg/mL | N/A |
Levofloxacin-resistant S. pneumoniae | 2 μg/mL | N/A |
H. influenzae with β-lactamase production | 0.03 μg/mL | N/A |
β-lactamase–positive, ampicillin-resistant H. influenzae | 0.12 μg/mL | N/A |
Ciprofloxacin-susceptible MSSA | 0.06 μg/mL | Moxifloxacin: 0.125μg/mL Gatifloxacin: 0.25 μg/mL |
Ciprofloxacin-resistant MSSA | 2 μg/mL | Moxifloxacin: 8 μg/mL Gatifloxacin:>8 μ g/mL |
Methicillin-susceptible S. epidermidis sensitive to ciprofloxacin | 0.06 μg/mL | Moxifloxacin: 0.125μg/mL Gatifloxacin: 0.25 μg/mL |
Methicillin-resistant S. epidermidis sensitive to ciprofloxacin | 0.06 μg/mL | Moxifloxacin: 0.125μg/mL Gatifloxacin: 0.25 μg/mL |
S. aureus parC S80Y + gyrA S84L double mutant | 0.5 μg/mL | Moxifloxacin: 0.5μg/mL Ciprofloxacin: 32 μg/mL |
S. pneumoniae parC S79Y + gyrA S81Y double mutant | 1 μg/mL | Moxifloxacin: 4μg/mL Ciprofloxacin:64 μg/mL |
Unpublished data Bausch & Lomb Inc.
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.